Research Article
T-HAD Score: A Novel Diagnostic Model for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD)
Table 1
Baseline characteristics of test cohort and validation cohort.
| | Test cohort (advanced fibrosis based on VCTE) | Validation cohort (advanced fibrosis based on liver biopsy) | Mean | Mean |
| Transient elastography | 7.3014660 | 8.971 | Sample size | 1617 | 84 | % of patients with advanced fibrosis | 13.9 | 21.42 | Height | 159.35 | 162.02 | Weight | 66.57 | 74.60 | Body mass index | 26.29 | 29.1 | Hip circumference | 95.38 | 90.33 | Aspartate aminotransferase | 35.75 | 69.39 | Alanine aminotransferase | 43.86 | 111.38 | Age | 43.36 | 43.93 | High-density lipoprotein | 50.34 | 40.04 | Triglycerides | 130.74 | 129.37 |
|
|
Abbreviations: VCTE = vibration-controlled transient elastography.
|